drugset / Trial / NCT02427646

Kinematic-guided BoNT-A Treatment for ET and PD Tremor

NCT02427646 ↗

Phase 2 Unknown 54 enrolled Western University, Canada
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The present study attempts to fill a critical knowledge gap of BoNT A in tremor management by studying the efficacy of IncobotulinumtoxinA (Xeomin®) injection for hand tremor in essential tremor and idiopathic Parkinson disease using data regarding composition of tremor obtained through sophisticated, yet clinically accessible multi-sensor based kinematic information.

Timeline

Start
2011-10
Primary completion
2015-04
Completion
2020-06

Outcome

Met primary endpoint

paper By week 38, the total FTM score statistically significantly reduced from 16.2±4.6 at week 0 to 9.5±6.3 (p<0.0005). PMID 27101283 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject BoNT-A Protein / enzyme biologic 50 iu Intramuscular
Subject BoNT-A Protein / enzyme biologic 300 iu Intramuscular

Indications